RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Update on Dyslipidemia and Cardiovascular Disease
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 15
SP 27
OP 29
DO 10.1177/155989771315017
UL http://mdc.sagepub.com/content/13/15/27.abstract
AB Despite the use of statins in patients who are dyslipidemic, residual risk of cardiovascular disease remains increased in many individuals [Libby P. J Am Coll Cardiol 2005]. New therapies are therefore needed to enhance the current standard of care for patients with high cardiometabolic risk [Chapman MJ et al. Eur Heart J 2009]. Key opinion leaders discussed the role of other available options for elevating high-density lipoprotein cholesterol.